Analystreport

Protagonist Therapeutics (NASDAQ:PTGX) was given a new $74.00 price target on by analysts at Johnson Rice.

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com